Patients with type 1 diabetes who used the i-Port Advance injection port for 12 weeks not only increased their satisfaction levels, but also experienced improvements in A1C levels, fasting blood glucose and postprandial glucose, according to a study in Diabetes & Metabolic Syndrome: Clinical Research & Reviews. The number of hypoglycemic episodes also significantly decreased with use of the i-Port Advance system.
Study looks at efficacy of i-Port Advance system in T1D
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.